1 INTRODUCTION (Page No. – 21)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 MAJOR MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. – 24)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 PROCEDURE-BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. – 34)
4 PREMIUM INSIGHTS (Page No. – 39)
4.1 HEMATOLOGY ANALYZERS AND REAGENTS MARKET OVERVIEW
4.2 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE
4.3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER
4.4 GEOGRAPHIC SNAPSHOT OF THE HEMATOLOGY ANALYZERS AND REAGENTS MARKET
5 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE (Page No. – 41)
5.1 INTRODUCTION
5.2 HEMATOLOGY PRODUCTS & SERVICES
5.2.1 REAGENTS & CONSUMABLES
5.2.1.1 Hematology reagents
5.2.1.1.1 Growing preference for reagent rental business models to boost the adoption of hematology reagents
5.2.1.2 Consumables
5.2.1.2.1 Consumables are reusable, inexpensive, and required in limited quantities; supporting their adoption
5.2.1.3 Controls & calibrators
5.2.1.3.1 Controls & calibrators offer the highest quality of lab results, have long-term stability, and are convenient to use
5.2.1.4 Slide stainers/makers
5.2.1.4.1 Automated slide stainers/makers help laboratories provide cost-efficient, reliable, and uniform staining results
5.2.2 INSTRUMENTS
5.2.2.1 5-part and 6-part fully automated hematology analyzers
5.2.2.1.1 Growing preference for 5-part and 6-part hematology analyzers due to their advantages to drive market growth
5.2.2.2 3-part fully automated hematology analyzers
5.2.2.2.1 3-part analyzers offer reduced maintenance costs, making them ideal cost-effective solutions for developing countries
5.2.2.3 Point-of-care testing hematology analyzers
5.2.2.3.1 Rising inclination towards home testing of blood levels will lead to market growth
5.2.2.4 Semi-automated hematology analyzers
5.2.2.4.1 Need for manual interruption will limit the adoption of these products
5.2.3 SERVICES
5.2.3.1 High adoption of hematology diagnostic techniques will aid market growth
5.3 HEMOSTASIS PRODUCTS & SERVICES
5.3.1 REAGENTS & CONSUMABLES
5.3.1.1 Rising prevalence of coagulation disorders to support growth
5.3.2 INSTRUMENTS
5.3.2.1 Hemostasis instruments offer outstanding productivity while reducing complexities and increasing output
5.3.3 SERVICES
5.3.3.1 Advancements in hemostasis diagnostic techniques will accelerate market growth
5.4 IMMUNOHEMATOLOGY PRODUCTS & SERVICES
5.4.1 REAGENTS & CONSUMABLES
5.4.1.1 Development of novel immunohematology reagents is supporting market growth
5.4.2 INSTRUMENTS
5.4.2.1 Growing automation in immunohematology labs to boost market growth
5.4.3 SERVICES
5.4.3.1 services enable customer-focused care—a key factor driving market growth
6 HEMATOLOGY ANALYZERS MARKET, BY PRICE RANGE (Page No. – 73)
6.1 INTRODUCTION
6.2 LOW-END HEMATOLOGY ANALYZERS
6.2.1 LOWER THROUGHPUT RATES AND REDUCED ACCURACY WILL HAMPER THE MARKET GROWTH IN THIS SEGMENT
6.3 HIGH-END HEMATOLOGY ANALYZERS
6.3.1 HIGH-END ANALYZERS OFFER ADVANTAGES SUCH AS RELIABILITY, HIGH ACCURACY, FLEXIBILITY, AND EASE OF USE
6.4 MID-RANGE HEMATOLOGY ANALYZERS
6.4.1 LOWER COST OF MID-RANGE HEMATOLOGY ANALYZERS IN COMPARISON WITH HIGH-END ANALYZERS—A KEY GROWTH DRIVER
7 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION (Page No. – 78)
7.1 INTRODUCTION
7.2 HEMORRHAGIC CONDITIONS
7.2.1 INCREASE IN HEMORRHAGIC CASES TO SUPPORT THE ADOPTION OF HEMATOLOGY INSTRUMENTS
7.3 INFECTION-RELATED CONDITIONS
7.3.1 GROWING BURDEN OF INFECTIOUS DISEASES TO SUPPORT THE ADOPTION OF HEMATOLOGY INSTRUMENTS
7.4 IMMUNE SYSTEM-RELATED CONDITIONS
7.4.1 RISING USE IN POINT-OF-CARE APPLICATIONS IS LIKELY TO AID THE ADOPTION OF HEMATOLOGY ANALYZERS & REAGENTS
7.5 BLOOD CANCER
7.5.1 HEMATOLOGY ANALYZERS ARE KEY INSTRUMENTS USED FOR THE DETERMINATION OF HEMATOLOGICAL MALIGNANCIES
7.6 ANEMIA
7.6.1 GROWING INCIDENCE OF ANEMIA TO SUPPORT THE ADOPTION OF HEMATOLOGY INSTRUMENTS
7.7 OTHER APPLICATIONS
8 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE (Page No. – 85)
8.1 INTRODUCTION
8.2 STANDALONE ANALYZERS
8.2.1 INCREASED USE OF STANDALONE ANALYZERS IN HOSPITALS AND REFERENCE LABS TO DRIVE MARKET GROWTH
8.3 POINT-OF-CARE ANALYZERS
8.3.1 SMALL SAMPLE REQUIREMENT LEADING TO INCREASED PREFERENCE FOR POC ANALYZERS AMONG END USERS
9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER (Page No. – 89)
9.1 INTRODUCTION
9.2 COMMERCIAL SERVICE PROVIDERS
9.2.1 GROWING OUTSOURCING WILL INCREASE THE MARKET GROWTH IN THIS SEGMENT
9.3 HOSPITAL LABORATORIES
9.3.1 HIGH PREVALENCE OF BLOOD-RELATED DISORDERS WILL RESULT IN HIGH MARKET GROWTH
9.4 GOVERNMENT REFERENCE LABORATORIES
9.4.1 AFFORDABILITY AND PROVISION OF FREE SERVICES ARE LIKELY TO PROPEL THE GROWTH OF THIS END-USER SEGMENT
9.5 RESEARCH & ACADEMIC INSTITUTES
9.5.1 INCREASING NUMBER OF DRUG DISCOVERY AND RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH
10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION (Page No. – 94)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Favorable research scenario will drive market growth in the US
10.2.2 CANADA
10.2.2.1 Rising demand for blood and blood components to support market growth
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Increasing number of anemic patients is a major factor driving the growth of the hematology analyzers and reagents market in Germany
10.3.2 UK
10.3.2.1 Government support to develop innovative diagnostic technologies contributing to market growth
10.3.3 FRANCE
10.3.3.1 Presence of proper protocols and guidelines in diagnostics to propel market growth in the coming years
10.3.4 ITALY
10.3.4.1 Increasing preference for hematology testing during transplantation will result in market growth
10.3.5 SPAIN
10.3.5.1 Consolidation of laboratories in Spain will drive market growth
10.3.6 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.1.1 Government initiatives and improving healthcare infrastructure
to aid growth 124
10.4.2 JAPAN
10.4.2.1 Rising prevalence of flu in Japan in recent years is contributing to market growth
10.4.3 INDIA
10.4.3.1 High burden of chronic diseases to support market growth
10.4.4 AUSTRALIA
10.4.4.1 Rising prevalence of celiac disease to support the use of hematology analyzers and reagents
10.4.5 SOUTH KOREA
10.4.5.1 Rising healthcare spending will support market growth
10.4.6 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 BRAZIL
10.5.1.1 Investments by leading hematology analyzer and reagent manufacturers in the country to drive market growth
10.5.2 MEXICO
10.5.2.1 Rising prevalence of diabetes and cancer to support market growth in Mexico
10.5.3 REST OF LATAM
10.6 MIDDLE EAST & AFRICA
10.6.1 MEA WILL HOLD A SMALLER SHARE AND GROW AT A LOWER RATE THAN THE MAJOR REGIONAL MARKETS
11 COMPETITIVE LANDSCAPE (Page No. – 148)
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES & APPROVALS
11.3.2 PARTNERSHIPS & COLLABORATIONS
11.3.3 MERGERS & ACQUISITIONS
11.3.4 MARKET EXPANSIONS
11.4 COMPETITIVE LEADERSHIP MAPPING
11.4.1 VISIONARY LEADERS
11.4.2 INNOVATORS
11.4.3 DYNAMIC DIFFERENTIATORS
11.4.4 EMERGING COMPANIES
